Envision Report

Published January 10, 2018

North America Cancer Therapy Market – Size, Outlook, Trends and Forecasts (2018 – 2024)

Request Free Sample Report!

Cancer therapies are drugs that are involved in reducing or blocking the growth of cancer by interacting with specific molecules which are responsible for the growth and spread of cancerous cells.

North America Cancer Therapy Market share:

North America Cancer Therapy market is segmented by treatment type, cancer type, targeted cancer therapeutics, application, and geography. On basics of targeted cancer therapeutics, targeted cancer is holding the most significant share due to the various increasing types of cancers and awareness regarding the molecular diagnostics.

North America Cancer Therapy Market size:

North America Cancer Therapy Market is accounted for USD XX billion in 2017 and expected to grow at a CAGR of X% to reach USD XX billion by 2024.

North America is occupying the most significant share in the market, especially in targeted therapies demand due to more number of market players and higher patient awareness levels.

North America Cancer Therapy Market growth:

The market for North America cancer therapy is driven by factors such rise in cancer incidences and access to modern therapeutics, the population of aged people, efficiency and high price manufacturers and innovations and increase in awareness regarding molecular diagnostic techniques that are influencing the market growth.

North America Cancer Therapy Market Industrial Analysis:

North America Cancer Therapy Market is segmented into treatment type, cancer type, therapeutics, application, and chemotherapy. By treatment type, the market is in surgery, chemotherapy, radiation therapy, targeted therapy, immune therapy, hormonal therapy, hyperthermia and stem cell transplant. By cancer type, the market is in blood therapy, bone cancer, brain cancer, breast cancer, endocrine cancer, eye cancer, gynecologic cancer, head and neck cancer, respiratory and skin cancer. By application, the market is a nasal spray, pills or tablets, skin gel, skin patches, vaginal creams or vaginal tablets and vaginal ring.

 North America Cancer Therapy Market Outlook:

North America Cancer Therapy market is expected to grow at a significant rate over the forecast period and is anticipated to perform well due to awareness regarding chronic diseases and cancer types. Many industries and firms are trying to develop new technologies and make advancements to improve the market.

North America Cancer Therapy Market Trends:

Novartis has completed acquired the France-based company AAA (Advanced Accelerator Application) in October 2017.

AstraZeneca is completed merged along with TerSera Therapeutics LLC in February 2017

North America Cancer Therapy Market Research Report Includes:

  • An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
  • To have complete market analysis through industry value chain analysisPorter’s fivePESTLESWOT analysis, and Y-o-Y analysis.
  • Regional and global diversity is analysed with the major countries and the unions.
  • Scrutinizing the revenue generation on YearOnYear
  • Identifying DROC in the current market and their impact in altering the market dynamics.
  • Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
  • Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
  • Identify the latest developments, market shares and strategies that are employed by the major market players, such as:
  • Bayer
  • GlaxoSmithKline Plc
  • Genentech Inc.
  • Abbott laboratories
  • Chugai Pharmaceutical Co., Ltd.

Chapter 1 Introduction

1.1 Executive Summary

1.2 Market Definition

1.3 Scope of the Study

Chapter 2 Research Methodology

2.1 Secondary Research

2.2 Primary Research

2.3 Analytic Tools and Model

2.4 Economic Indicator

     2.4.1 Base Year, Base Currency, Forecasting Period

2.5 Expert Validation

2.6 Study Timeline

Chapter 3 Market Analysis

3.1 Industry Value Chain Analysis

3.2 Porter’s Five Analysis

3.2.1 Bargaining Power of Buyers

3.2.2 Bargaining Power of Suppliers

3.2.3 Threats of Substitutes

3.2.4 Threats of New Entrants

3.2.5 Industry Rivalry

3.3 PESTLE Analysis

3.3.1 Political

3.3.2 Economical

3.3.3 Social

3.3.4 Technological

3.3.5 Legal

3.3.6 Environmental

3.4 SWOT Analysis

3.4.1 Strengths

3.4.2 Weakness

3.4.3 Opportunities

3.4.4 Threats

3.5 Y-O-Y Analyses

Chapter 4 Market Dynamics

4.1 DROC

4.1.1 Drivers

4.1.2 Restraints

4.1.3 Opportunities

4.1.4 Challenges

Chapter 5 Market Segmentation Analysis

Chapter 6 Market Segmentation by Treatment Type

6.1 Chemotherapy

6.2 Surgery

6.3 Radiation Therapy

6.4 Immunotherapy

6.5 Targeted Therapy

6.6 Signal Transduction Inhibitors

6.7 Stem Cell Transplant

6.8 Hormonal Therapy

6.9 Apoptosis Inducers

6.10 Others

Chapter 7 Market Segmentation by Cancer Type

7.1 Eye Cancer

7.2 Bone Cancer

7.3 Brain Cancer

7.4 Blood Cancer

7.5 Endocrine Cancer

7.6 Skin Cancer

7.7 Others

Chapter 8 Market Segmentation by Targeted Cancer Therapeutics

8.1 Hormone Therapy

8.2 Targeted Cancer Therapeutics

8.3 Signal Transduction Inhibitors

8.4 Immunotherapies

8.4.1 Monoclonal Antibodies Naked Monoclonal Antibodies Conjugated Monoclonal Antibodies Radiolabeled Antibodies Chemolabeled Antibodies

8.5 Cancer Vaccines

8.6 Non-Specific Immunotherapies

8.7 Others

Chapter 9 Market Segmentation by Application

9.1 Nasal Spray

9.2 Pills or Tablets

9.3 Skin Gel

9.4 Skin Patches

9.5 Vaginal Ring

9.6 Others

Chapter 10 Market Segmentation by Geography

10.1 North America

10.1.1 Introduction

10.1.2 United States

10.1.3 Canada

10.1.4 Mexico

10.1.5 Others

Chapter 11 Competitive Landscape

11.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements

11.2 Market Share Analysis

11.3 Strategies Adopted By Top Companies

Chapter 12 Company Profiles

12.1 Genentech Inc.

12.1.1. Company Overview

12.1.2. Financial Performance

12.1.3. Product Benchmarking

12.1.4. Strategic Initiative

12.2 GlaxoSmithKline Plc

12.3 AstraZeneca Plc

12.4 Chugai Pharmaceutical Co., Ltd.

12.5 GPC Biotech Ag

12.6 Novartis

12.7 OSI Pharmaceuticals, Inc.

12.8 Pfizer

12.9 Abbott laboratories

12.10 Sanofi

12.11 Aveo pharmaceuticals

12.12 Hospira Inc.,

12.13 Bayer

12.14 Boehringer Ingelheim GmbH

Chapter 13 Market Estimates and Forecasting

13.1 Market Estimates and Forecasting 2018-2024(USD Million)

13.1.1 Market Estimation and Forecasting by Treatment Type 2018-2024 (USD Million)

13.1.2 Market Estimates and Forecasting by Cancer Type 2018-2024 (USD Million)

13.1.3 Market Estimates and Forecasting for Targeted Cancer Therapeutics 2018-2024 (USD Million)

13.1.4 Market Estimates and Forecasting by Application 2018-2024 (USD Million)

13.1.5 Market Estimates and Forecasting by Geography 2018-2024 (USD Million)

 Chapter 14 Market Insights

14.1 Insights of Industry Experts

14.2 Analyst Opinion (Market Understanding)

14.3 Investment Opportunities

Chapter 15 Appendix

15.1 List of Tables

15.2 List of Figures

  • Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
  • Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
  • The Regional and Global Variety is taken care of in the report.
  • Year on Year basis generation of revenue is studied.
  • Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
  • The overview and the sustainability of the market are analyzed through SWOT.
  • DROC is recognized in the current market scenario and see how its effect on market dynamics.
  • The segment-level analysis in terms of type and technology.
  • The value chain analysis, value that's created and captured by a company is the profit margin.Value
  • Created and Captured – Cost of Creating that Value = Margin
  • An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
  • Basis on the depth of the study we approach using analytical tools
  • Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.


©2018 - Envision Inteligence | All Rights Reserved.